Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors
Molecular Oncology · 2024-11 · 18 (11) · 2649-2657
DOI: 10.1002/1878-0261.13557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 23.12.2023. Verfasst von Ekaterina Kalashnikova und 18 weiteren Autor:innen. Beteiligte Einrichtung: Natera, Inc., Austin, TX, USA. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms, Gene Frequency, Tumor Burden. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Several studies have demonstrated the prognostic value of circulating tumor DNA (ctDNA); however, the correlation of mean tumor molecules (MTM)/ml of plasma and mean variant allele frequency (mVAF; %) with clinical parameters is yet to be understood. In this study, we analyzed ctDNA data in a pan‐cancer cohort of 23 543 patients who had ctDNA testing performed using a personalized, tumor‐informed assay (Signatera™, mPCR‐NGS assay). For ctDNA‐positive patients, the correlation between MTM/ml and mVAF was examined. Two subanalyses were performed: (a) to establish the association of ctDNA with tumor volume and (b) to assess the correlation between ctDNA dynamics and patient outcomes. On a global cohort, a positive correlation between MTM/ml and mVAF was observed. Among 18 426 patients with longitudinal ctDNA measurements, 13.3% had discordant trajectories between MTM/ml and mVAF at subsequent time points. In metastatic patients receiving immunotherapy ( N = 51), changes in ctDNA levels expressed both in MTM/ml and mVAF showed a statistically significant association with progression‐free survival; however, the correlation with MTM/ml was numerically stronger.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natera, Inc., Austin, TX, USA.
ORCID-Profile: Alexey Aleshin
Zitieren
APA
Kalashnikova, E., Aushev, V. N., Malashevich, A. K., Tin, A., Krinshpun, S., Salari, R., Scalise, C. B., Ram, R., Malhotra, M., Ravi, H., Sethi, H., Sanchez, S., Hagelstrom, R. T., Brevnov, M., Rabinowitz, M., Moshkevich, S., Zimmermann, B. G., Liu, M. C., & Aleshin, A. (2024). Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors. Molecular Oncology, 18(11), 2649-2657. https://doi.org/10.1002/1878-0261.13557
Vancouver
Kalashnikova E, Aushev VN, Malashevich AK, Tin A, Krinshpun S, Salari R, et al. Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors. Molecular Oncology. 2024;18(11):2649-2657. doi:10.1002/1878-0261.13557
BibTeX
@article{Kalashnikova2024,
author = {Kalashnikova, Ekaterina and Aushev, Vasily N and Malashevich, Allyson Koyen and Tin, Antony and Krinshpun, Shifra and Salari, Raheleh and Scalise, Carly Bess and Ram, Rosalyn and Malhotra, Meenakshi and Ravi, Harini and Sethi, Himanshu and Sanchez, Stephanie and Hagelstrom, Robert Tanner and Brevnov, Maxim and Rabinowitz, Matthew and Moshkevich, Solomon and Zimmermann, Bernhard G and Liu, Minetta C and Aleshin, Alexey},
title = {Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors},
journal = {Molecular Oncology},
year = {2024},
volume = {18},
number = {11},
pages = {2649--2657},
doi = {10.1002/1878-0261.13557}
}
EUVIMED